Eoflow invests KRW 10.85 billion in Gonjiam plant expansion and automation

Eoflow announced a facility investment of KRW 10.85 billion for expansion and renovation of its Gonjiam plant and construction of an automated production line for Eopatch wearable insulin pumps. The project is expected to be completed by December 2022.

“곤지암 신공장은 우리 회사의 새로운 원동력이 될 것이며, 이를 통해 글로벌 웨어러블 인슐린 펌프 전문기업으로 한 걸음 더 나아가게 될 것”pharmnews.com

• 1 source
• pharmnews.com이오플로우, 곤지암 신공장 신규시설 투자 결정 < 의료기기 < 산업 < 기사본문 - 팜뉴스김태일 기자May 31, 2022

Summarized from public sources; check the original articles before acting on it.